ReviewApplied biochemistry and biotechnology2026
Recent Advances in the Manufacturing of Furfurylamine Through Biological and Chemobiological Ways.
Review in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Comprehensive Review of Recent Advances in Sustainable Synthesis of Bio-Based Furanic Compounds Via Chemical, Biological, Chemobiological and Other Combination Approach in Benign Systems.Applied biochemistry and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Catalytic upgrading of biomass is of paramount importance for the sustainable production of bio-based chemicals and biofuels. The direct use of polysaccharides, such as xylan and glucan, as starting materials is also possible in the preparation of biofurans. As one valuable biofuran, furfurylamine is recognized as a versatile intermediate, it is extensively used in manufacturing perfumes, resins, fibers, additives, and medicines. This review explores a sustainable approach to furfurylamine production that can be obtained entirely from agricultural and forestry wastes, including corncob, corn stalk, oat, and wheat bran. The procedure entails the hydrolysis of hemicellulose in biomass to liberate pentoses, succeeded by the dehydration of pentoses to generate furfural, which is then transformed into furfurylamine through biological amination. Key parameters such as catalyst selection, reaction conditions, and process optimization were investigated to enhance yield and selectivity. The results demonstrate the feasibility of manufacturing furfurylamine from hemicellulose-rich biomass, with significant advantages in terms of sustainability, cost-effectiveness, and reduced environmental impact compared to conventional methods. A life cycle assessment (LCA) and economic analysis further highlight the potential of this biomass-based route as a viable alternative to petrochemical processes. This review summarizes the recent advances, challenges and prospects of furfurylamine production from biomass, which provides a reference to the growing field of green chemistry by valorizing agricultural waste and providing a scalable, eco-friendly pathway for furfurylamine production via biological and chemobiological approach.
Indexed as
Identifiers
41843008What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.